Antares Pharma, Inc.Ewing, NJ United States
Company Description
Antares Pharma understands antagonism towards needles. The company develops needle-free systems for administering injectable drugs. Its Medi-Jector Vision system, for instance, injects a thin, high-pressure stream of liquid, eliminating the need for a needle. The Vision system is used primarily for the delivery of insulin and of human growth hormones; it is available over-the-counter and by prescription in the US and is also sold overseas. In addition to its needle-free systems, the company develops other drug-delivery platforms, including topical gels, orally administered disintegrating tablets, and mini-needle injection systems.
| 250 Phillips Blvd., Ste. 290 | Phone: 609-359-3020 | http://www.antarespharma.com |
| Ewing, NJ 08618 | Fax: 609-359-3015 | |
| United States |
Antares Pharma, Inc. Rankings
| Russell 2000 (June 2011) |
Executives
| 20 executives listed for Antares Pharma, Inc.'s Ewing, NJ location. | ||
| Chairman | Leonard Jacob | |
|---|---|---|
| President, CEO, and Director | Paul Wotton | |
| EVP, CFO, Corporate Secretary; President, Parenteral Products | RobertApple | |
Financials
| Company Type | Public - NYSE Amex: AIS Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 29 |
Leverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Antares Pharma, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
